Vitronectin-Mediated Endocytosis

Vitronectin-mediated endocytosis is a cellular process in which asbestos fibers become coated with a blood and tissue protein called vitronectin, which then helps lung and mesothelial cells pull the fibers inside themselves. Once internalized, the fibers can damage DNA, generate reactive oxygen species, and trigger chronic inflammation. This uptake mechanism is one of the ways that biologically durable asbestos fibers cause cellular injury rather than simply sitting inertly in tissue.

Origin

Vitronectin was identified in the 1980s as a glycoprotein in blood and extracellular matrix that promotes cell adhesion through integrin receptors. Researchers in the 1990s and 2000s, studying why long, thin amphibole fibers are taken up by mesothelial cells, demonstrated that vitronectin coats asbestos fibers and bridges them to integrin receptors (notably αvβ5) on the cell surface, enabling endocytosis.

Significance in Asbestos Context

This mechanism helps explain how microscopic asbestos fibers cause disease at the cellular level. They are not passively inhaled and ignored by the body, but actively pulled into cells lining the lungs and pleura, where they cause repeated DNA damage over decades. For patients, this matters because it underlies the long latency between exposure and disease, and it supports the scientific consensus that even relatively low cumulative exposures to durable fibers can initiate the biological cascade leading to mesothelioma or lung cancer. In expert reports and depositions, defense experts sometimes argue that low-dose exposures are biologically irrelevant; mechanistic evidence like vitronectin-mediated uptake is part of what plaintiff experts cite to rebut that argument.

Example Sentence

The plaintiff's cellular biology expert explained vitronectin-mediated endocytosis to the jury to show how even brief exposures to amphibole fibers can produce ongoing injury at the cellular level for the rest of a person's life.

Related Terms

Reactive Oxygen Species, Frustrated Phagocytosis, Mesothelial Cells, Fiber Biopersistence, Chronic Inflammation, Integrins

Notes

• If your case involves disputes over low-dose or short-duration exposure, ask your legal team whether their expert reports address cellular uptake mechanisms, including vitronectin-mediated endocytosis, to counter "threshold" defense arguments.
• Preserve any pathology reports and tissue blocks from biopsies. Mechanistic experts can sometimes correlate fiber burden and cellular changes to strengthen causation testimony.
• This is a mechanistic concept, not a diagnostic test; you will not see it on your medical records, but it may appear in expert witness reports and scientific literature cited in your case.
• If you want to understand the biology behind your diagnosis, ask your oncologist or a patient advocate for plain-language resources on how asbestos fibers injure cells, rather than trying to read primary research alone.